Valuation : ConvaTec Group Plc

Market Cap 603.05Cr 518.93Cr 488.24Cr 446.01Cr 834.34Cr 57TCr 836.62Cr 5.77TCr 2.24TCr 29TCr 2.26TCr 2.22TCr 94TCr P/E 2026 *
24x
P/E 2027 * 16.7x
Enterprise Value 741.7Cr 638.24Cr 600.49Cr 548.55Cr 1.03TCr 70TCr 1.03TCr 7.1TCr 2.75TCr 36TCr 2.79TCr 2.72TCr 1,15700Cr EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.65x
Free-Float
95.15%
Yield 2026 *
2.58%
Yield 2027 * 2.95%
1 day+0.35%
1 week+0.26%
Current month+0.26%
1 month-0.52%
3 months+11.75%
6 months-6.17%
Current year-6.17%
1 week 225.2
Extreme 225.2
235.4
1 month 223.2
Extreme 223.2
237.2
Current year 193
Extreme 193
259.3
1 year 193
Extreme 193
259.3
3 years 193
Extreme 193
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
26/05/26 Buy

Chief Executive Officer

50,000 0.0026%
26/05/26 Buy

Chief Financial Officer

24,993 0.0013%
17/03/26 Exercice

Chief Executive Officer

1,06,137 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%+0.26% - - 603.05Cr
Average +0.35%
Weighted average by Cap. +0.35%

Financials

2026 *2027 *
Net sales 255.56Cr 219.91Cr 206.91Cr 189.01Cr 353.58Cr 24TCr 354.54Cr 2.44TCr 948.75Cr 12TCr 959.66Cr 938.73Cr 40TCr 273.34Cr 235.21Cr 221.3Cr 202.15Cr 378.17Cr 26TCr 379.2Cr 2.61TCr 1.01TCr 13TCr 1.03TCr 1TCr 43TCr
Net income 25Cr 21Cr 20Cr 18Cr 34Cr 2.34TCr 34Cr 237.5Cr 92Cr 1.2TCr 93Cr 91Cr 3.87TCr 36Cr 31Cr 29Cr 27Cr 50Cr 3.4TCr 50Cr 344.1Cr 133.52Cr 1.74TCr 135.06Cr 132.11Cr 5.61TCr
Net Debt 138.65Cr 119.31Cr 112.25Cr 102.54Cr 191.83Cr 13TCr 192.35Cr 1.33TCr 514.73Cr 6.72TCr 520.65Cr 509.29Cr 22TCr 120.91Cr 104.04Cr 98Cr 89Cr 167.28Cr 11TCr 167.74Cr 1.16TCr 448.87Cr 5.86TCr 454.03Cr 444.13Cr 19TCr
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
04/26/04 GBX 228.20 +0.35% 75,06,331
03/26/03 GBX 227.40 -2.65% 79,12,174
02/26/02 GBX 233.60 +1.65% 49,11,132
01/26/01 GBX 229.80 +0.97% 83,84,676
28/26/28 GBX 227.60 -0.87% 2,36,23,015
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.086USD
Average target price
4.053USD
Spread / Average Target
+31.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CTEC Stock